[ET Net News Agency, 21 January 2021] Daiwa Research initiated coverage on Alibaba
Health Information Technology (ALH) (00241) with a "buy" rating and a target price of
HK$32.8.
The research house sees ALH as one of the early-movers among China's HealthTech digital
new infrastructure creators with a unique presence in some niche areas.
Daiwa said ALH, 68% jointly owned by Alibaba (09988), YF Capital and Ant Group, also
benefits from Alibaba Group's ecosystems, including (1) access to retail user traffic from
China's leading online shopping portals (Tmall and Taobao) and FinTech gateway (Alipay),
(2) leveraging the service capacity of partners under Alibaba's ecosystem, such as payment
services supported by Ant Group, and fast-drug-delivery services enabled by Ele.me and
Koubei, and (3) enjoying its ecosystem partners' strong technology capabilities in cloud
computing, Big Data and AI to offer participants with intelligent digital solutions. (KL)